Preconditioning with XNJ attenuated the neuronal apoptosis induced by sevoflurane in a dose‐dependent manner. Anesthesia reduced the expression of p-AKT (phosphorylated at sites Thr308 and Ser473) and phosphorylated extracellular-regu- lated protein kinase (p-ERK) in the striatum. Pre-treatment with
ZHOU-JING YANG,YING-WEI WANG,LI CHANG-LIN,MA LI-QING,XUAN ZHAO
2014-01-01
Abstract:Xingnaojing (XNJ), is a standardized Chinese herbal medicine product derived from An Gong Niu Huang Pill. It may be involved in neuroprotection in a number of neurological disorders. Exposure to anesthetic agents during the brain growth spurt may trigger widespread neuroapoptosis in the developing brain. Thus the present study aimed to identify whether there was a neuroprotective effect of XNJ on anesthesia-induced neuroapoptosis. Seven-day-old rats received treatment with 2.1% sevoflurane for 6 h. Rat pups were injected intraperitoneally with 1 or 10 ml/kg XNJ at 0.2, 24 and 48 h prior to sevoflurane exposure. The striata of neonatal rats were collected following administration of anesthesia. Western blotting and immunohistochemistry were used to analyze the expression of activated caspase 3, Bax and phosphorylated protein kinase B (p-AKT) in the striatum. It was found that activated caspase 3 and Bax expression were upregulated in the striatum following sevoflurane treatment. Preconditioning with XNJ attenuated the neuronal apoptosis induced by sevoflurane in a dose‐dependent manner. Anesthesia reduced the expression of p-AKT (phosphorylated at sites Thr308 and Ser473) and phosphorylated extracellular-regulated protein kinase (p-ERK) in the striatum. Pre-treatment with XNJ reversed the reduction in p-AKT, but not p-ERK expression. These data suggest that XNJ has an antiapoptotic effect against sevoflurane‐induced cell loss in the striatum. It thus holds promise as a safe and effective neuroprotective agent. The action of XNJ on p‐AKT may make a significant contribution to its neuroprotective effect. Introduction Sevoflurane is a widely‐used volatile anesthetic for the induction and maintenance of general anesthesia, particularly in pediatric anesthesia, due to its rapid induction and the rapid recovery of patients. It has been reported that exposure of the neonatal nervous system to sevoflurane may lead to widespread neurodegeneration in a number of regions of the developing rat brain and that it may cause learning abnormalities in mice (1,2). The process of cell death triggered by sevoflurane exhibits all the classical ultrastructural characteristics of apoptosis (3-5) and is known to be regulated by the Bax-dependent intrinsic pathway, involving cytochrome c release from the mitochondria and activation of the caspase cascade (6-8). Currently there is no available prophylactic treatment to prevent anesthesia-induced neuroapoptosis. An Gong Niu Huang Pill is a well-known traditional Chinese medicine used in the treatment of certain neurological disorders. It contains Calculus bovis, Cornu bubali, Cinnabar, Curcuma aromatica, Scutellaria, Coptidis rhizoma and Fructus gardenia (30 g of each), Moschus and Borneo camphor (7.5 g of each) and Concha margaritifera (15 g) (9). Xingnaojing (XNJ), an extract of An Gong Niu Huang Pill, predominantly contains Moschus (Moschus berezovskii F.; 7.5 g), Radix curcumae (Curcuma wenyujin Y.H.Chen & C.Ling, Zingiberaceae; 30 g), Borneolum (Blumea balsamifera DC, Compositae; 1 g) and Fructus gardenia (Gardenia jasminoides J.Ellis, Rubiaceae; 30 g) (10). XNJ is a herbal preparation of moschus, borneolum, Fructus gardenia and Radix curcumae and is primarily used in the treatment of neurological diseases, including brain ischemia, neurotoxic damage, cerebral hemorrhage, bacterial and viral meningitis and vascular dementia (10-12). It is unclear whether XNJ may protect against sevoflurane‐induced neuronal apoptosis in the developing brain. Thus, the present study was designed to investigate the possible neuroprotective effects of XNJ, and to attempt to elucidate the underlying mechanisms of any such effects. Materials and methods Preparation and quality control of XNJ. XNJ was obtained from Wuxi Jiminkexin Shanhe Pharmaceutical Co., Ltd. (Wuxi, China) with the Chinese Food and Drug Administration Pre-treatment with a Xingnaojing preparation ameliorates sevoflurane-induced neuroapoptosis in the infant rat striatum ZHOU-JING YANG, YING-WEI WANG, CHANG-LIN LI, LI-QING MA and XUAN ZHAO Department of Anesthesiology and Intensive Care Medicine, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200092, P.R. China Received January 27, 2014; Accepted August 22, 2014 DOI: 10.3892/mmr.2014.2934 Correspondence to: Dr Xuan Zhao, Department of Anesthesiology and Intensive Care Medicine, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, 1665 Kongjiang Road, Shanghai 200092, P.R. China E-mail: zhaoxuan0323@hotmail.com